Responsible use of organoids in precision medicine: the need for active participant involvement
Open Access
- 1 April 2020
- journal article
- review article
- Published by The Company of Biologists in Development
- Vol. 147 (7)
- https://doi.org/10.1242/dev.177972
Abstract
Organoids are three-dimensional multicellular structures grown in vitro from stem cells and which recapitulate some organ function. They are derivatives of living tissue that can be stored in biobanks for a multitude of research purposes. Biobank research on organoids derived from patients is highly promising for precision medicine, which aims to target treatment to individual patients. The dominant approach for protecting the interests of biobank participants emphasizes broad consent in combination with privacy protection and ex ante (predictive) ethics review. In this paradigm, participants are positioned as passive donors; however, organoid biobanking for precision medicine purposes raises challenges that we believe cannot be adequately addressed without more ongoing involvement of patient-participants. In this Spotlight, we argue why a shift from passive donation towards more active involvement is particularly crucial for biobank research on organoids aimed at precision medicine, and suggest some approaches appropriate to this context.Keywords
This publication has 79 references indexed in Scilit:
- The truth about the truth: What matters when privacy and anonymity can no longer be promised to those who participate in clinical trial research?Research Ethics, 2013
- Biobanking: shifting the analogy from consent to surrogacyGenetics in Medicine, 2012
- Genetic adaptation to high altitude in the Ethiopian highlandsGenome Biology, 2012
- Power to the people: a wiki-governance model for biobanksGenome Biology, 2012
- Can Broad Consent be Informed Consent?Public Health Ethics, 2011
- Reflexive governance in biobanking: on the value of policy led approaches and the need to recognise the limits of lawHuman Genetics, 2011
- Public Perspectives on Informed Consent for BiobankingAmerican Journal of Public Health, 2009
- Developing Stakeholder Involvement for Introducing Public Health Genomics into Public PolicyPublic Health Genomics, 2008
- Partnership in U.K. Biobank: A Third Way for Genomic Property?Journal of Law, Medicine & Ethics, 2007
- Potential harms, anonymization, and the right to withdraw consent to biobank researchEuropean Journal of Human Genetics, 2005